These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32697408)

  • 1. Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.
    Spies M; Nasser A; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    Hum Brain Mapp; 2020 Nov; 41(16):4518-4528. PubMed ID: 32697408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
    Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
    Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.
    Herth MM; Petersen IN; Hansen HD; Hansen M; Ettrup A; Jensen AA; Lehel S; Dyssegaard A; Gillings N; Knudsen GM; Kristensen JL
    Nucl Med Biol; 2016 Aug; 43(8):455-62. PubMed ID: 27209485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.
    Ettrup A; da Cunha-Bang S; McMahon B; Lehel S; Dyssegaard A; Skibsted AW; Jørgensen LM; Hansen M; Baandrup AO; Bache S; Svarer C; Kristensen JL; Gillings N; Madsen J; Knudsen GM
    J Cereb Blood Flow Metab; 2014 Jul; 34(7):1188-96. PubMed ID: 24780897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans.
    Erritzoe D; Holst K; Frokjaer VG; Licht CL; Kalbitzer J; Nielsen FA; Svarer C; Madsen J; Knudsen G
    J Neurosci; 2010 Mar; 30(9):3391-7. PubMed ID: 20203198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.
    Ettrup A; Palner M; Gillings N; Santini MA; Hansen M; Kornum BR; Rasmussen LK; Någren K; Madsen J; Begtrup M; Knudsen GM
    J Nucl Med; 2010 Nov; 51(11):1763-70. PubMed ID: 20956470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levels.
    Klein AB; Trajkovska V; Erritzoe D; Haugbol S; Madsen J; Baaré W; Aznar S; Knudsen GM
    J Cereb Blood Flow Metab; 2010 Nov; 30(11):e1-7. PubMed ID: 20736957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
    Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C
    Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.
    Madsen MK; Fisher PM; Stenbæk DS; Kristiansen S; Burmester D; Lehel S; Páleníček T; Kuchař M; Svarer C; Ozenne B; Knudsen GM
    Eur Neuropsychopharmacol; 2020 Apr; 33():71-80. PubMed ID: 32146028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
    Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
    Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
    Ettrup A; Hansen M; Santini MA; Paine J; Gillings N; Palner M; Lehel S; Herth MM; Madsen J; Kristensen J; Begtrup M; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):681-93. PubMed ID: 21174090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
    Laje G; Cannon DM; Allen AS; Klaver JM; Peck SA; Liu X; Manji HK; Drevets WC; McMahon FJ
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):715-24. PubMed ID: 20047709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
    Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
    Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin.
    Hautzel H; Müller HW; Herzog H; Grandt R
    Neuroimage; 2011 Oct; 58(3):905-11. PubMed ID: 21722741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research.
    Holze F; Madsen MK; Svarer C; Gillings N; Stenbaek DS; Rudin D; Duthaler U; Liechti ME; Fisher PM; Knudsen GM
    Eur Neuropsychopharmacol; 2024 Nov; 88():43-48. PubMed ID: 39121715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trait aggression and trait impulsivity are not related to frontal cortex 5-HT2A receptor binding in healthy individuals.
    da Cunha-Bang S; Stenbæk DS; Holst K; Licht CL; Jensen PS; Frokjaer VG; Mortensen EL; Knudsen GM
    Psychiatry Res; 2013 May; 212(2):125-31. PubMed ID: 23137806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.
    Kroll T; Elmenhorst D; Matusch A; Wedekind F; Weisshaupt A; Beer S; Bauer A
    Mol Imaging Biol; 2013 Aug; 15(4):456-67. PubMed ID: 23456885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convergent
    Petersen IN; Villadsen J; Hansen HD; Jensen AA; Lehel S; Gillings N; Herth MM; Knudsen GM; Kristensen JL
    Bioorg Med Chem; 2016 Nov; 24(21):5353-5356. PubMed ID: 27624522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective 5-HT
    Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
    Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.